Conjoint Professor

Professor David Goldstein

MBBS, FRACP, PRCP (UK)

Medicine & Health
School of Clinical Medicine

Prof Goldstein is a Conjoint Clinical Professor. He has been involved in a variety of clinical research projects ranging from laboratory basic science to novel therapeutics trials to psychosocial aspects of Cancer care. He has been PI of a number of NHMRC and Cancer Australia funded therapeutic trials including both investigator initiated and as Australian PI for multinational studies. He has also been involved with psychosocial and cross cultural/CALD research for many years. His clinical interests are treatment of GI malignancies including pancreas cancer, colorectal cancer, anal carcinoma, hepatobilary and upper GI malignancy and renal cell carcinoma and lymphoma.

Prof Goldstein has been a Chief or Principal Investigator on $39,000,000 peer reviewed funded grants. He was the Director of the UNSW Translational Cancer Research Network, a $6,000,000 5 year CINSW funded program now completed. He was the adult program leader of the UNSW National Cancer Survivors Centre and is involved with a research program associated with survivorship issues. As part of this activity, he was the Chief Investigator of a 5 year Cancer Institute NSW translational program grant of $3,100,000 to study the impact of chemotherapy induced peripheral neuropathy, now completed.

He also actively participates in two laboratory research programs dealing with stromal biology, pancreas drug resistance and modelling optimal targeted therapies.

Prof Goldstein has 370 co-authored peer reviewed publications, since 2017 citations 17460, overall 33917, H index 80, since 2017 56 [Google Scholar]. He has presented at numerous national and international meetings: ESMO- ESMO Asia, ESMO GI, USA – ASCO, Japan - Japan Pancreas Society, Gastro week and medical oncology group, New Zealand, S. Korea, Singapore, COSA ASM.

National and international collaborations with researchers at University of Sydney, MRC (UK), University of Liverpool, GERCOR, NCIC. Invited reviewer for leading scientific journals, and grant applications (NHMRC, ARC).

 

 

 

Phone
22577
Location
lowy cancer centre
  • Journal articles | 2023
    Clifford BK; Amorim N; Kaakoush N; Boysen L; Tedla N; Goldstein D; Hardeman E; Simar D, 2023, 'Irradiation-Induced Dysbiosis: The Compounding Effect ofHigh-Fat Diet on Metabolic and Immune Functions in Mice', International Journal of Molecular Sciences, vol. 24, pp. 5631 - 5631, http://dx.doi.org/10.3390/ijms24065631
    Journal articles | 2023
    Lam LL; Pavlakis N; Shitara K; Sjoquist KM; Martin AJ; Yip S; Kang YK; Bang YJ; Chen LT; Moehler M; Bekaii-Saab T; Alcindor T; O’Callaghan CJ; Tebbutt NC; Hague W; Chan H; Rha SY; Lee KW; Gebski V; Jaworski A; Zalcberg J; Price T; Simes J; Goldstein D, 2023, 'INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)', BMC Cancer, vol. 23, http://dx.doi.org/10.1186/s12885-023-10642-7
    Journal articles | 2023
    Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB, 2023, 'Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 21, pp. 125 - 132, http://dx.doi.org/10.6004/jnccn.2022.7074
    Journal articles | 2023
    Mizrahi D; Goldstein D; Trinh T; Li T; Timmins HC; Harrison M; Marx GM; Hovey EJ; Lewis CR; Friedlander M; Park SB, 2023, 'Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy', Asia-Pacific Journal of Clinical Oncology, vol. 19, pp. 243 - 249, http://dx.doi.org/10.1111/ajco.13834
    Journal articles | 2023
    Timmins HC; Mizrahi D; Li T; Kiernan MC; Goldstein D; Park SB, 2023, 'Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review', Journal of Cancer Survivorship, vol. 17, pp. 222 - 236, http://dx.doi.org/10.1007/s11764-021-00988-x
    Journal articles | 2023
    de Guzman RB; Chua MLK; Goldstein D; Aung S; Eaton V; Park K, 2023, 'ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia Pacific', JCO global oncology, vol. 9, pp. e2200313, http://dx.doi.org/10.1200/GO.22.00313
    Journal articles | 2022
    Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2022, 'Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients', Patient Education and Counseling, vol. 105, pp. 452 - 459, http://dx.doi.org/10.1016/j.pec.2021.05.018
    Journal articles | 2022
    Butow P; Davies G; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub T; Thomas DM; Goldstein D; Best MC, 2022, 'Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study', Journal of Genetic Counseling, vol. 31, pp. 96 - 108, http://dx.doi.org/10.1002/jgc4.1455
    Journal articles | 2022
    Butow PN; Best MC; Davies G; Schlub T; Napier CE; Bartley N; Ballinger ML; Juraskova I; Meiser B; Goldstein D; Biesecker B; Thomas DM, 2022, 'Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients', Patient Education and Counseling, vol. 105, pp. 2206 - 2216, http://dx.doi.org/10.1016/j.pec.2022.01.011
    Journal articles | 2022
    Foo T; Goldstein D; Segelov E; Shapiro J; Pavlakis N; Desai J; Yip D; Zalcberg J; Price TJ; Nagrial A; Chantrill L; Burge M; Karapetis CS; Tebbutt N; Roy AC, 2022, 'The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours', Targeted Oncology, vol. 17, pp. 95 - 110, http://dx.doi.org/10.1007/s11523-022-00869-y
    Journal articles | 2022
    Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M, 2022, 'Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)', Frontiers in Immunology, vol. 13, http://dx.doi.org/10.3389/fimmu.2022.1060957
    Journal articles | 2022
    Livni L; Keating BA; Fiore NT; Lees JG; Goldstein D; Moalem-Taylor G, 2022, 'Effects of combined chemotherapy and anti-programmed cell death protein 1 treatment on peripheral neuropathy and neuroinflammation in mice', Pain, vol. 163, pp. 110 - 124, http://dx.doi.org/10.1097/j.pain.0000000000002384
    Journal articles | 2022
    Maharaj AD; Evans SM; Ioannou LJ; Croagh D; Earnest A; Holland JF; Pilgrim CHC; Neale RE; Goldstein D; Kench JG; Merrett ND; White K; Burmeister EA; Evans PM; Hayes TM; Houli N; Knowles B; Leong T; Nikfarjam M; Philip J; Quinn M; Shapiro J; Smith MD; Spillane JB; Wong R; Zalcberg JR, 2022, 'The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer', HPB, vol. 24, pp. 950 - 962, http://dx.doi.org/10.1016/j.hpb.2021.11.005
    Journal articles | 2022
    Mcnamara MG; Bridgewater J; Goyal L; Jacobs T; Wagner AD; Goldstein D; Shroff R; Moehler M; Lowery M; Bekaii-Saab T; Kelley RK; Furuse J; Rimassa L; Morizane C; Lamarca A; Hubner R; Knox J; Valle J, 2022, 'What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature', BMJ Open, vol. 12, pp. e064954, http://dx.doi.org/10.1136/bmjopen-2022-064954
    Journal articles | 2022
    Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Tucker K; Goldstein D; Biesecker BB; Best MC, 2022, 'Psychological predictors of advanced cancer patients’ preferences for return of results from comprehensive tumor genomic profiling', American Journal of Medical Genetics, Part A, vol. 188, pp. 725 - 734, http://dx.doi.org/10.1002/ajmg.a.62563
    Journal articles | 2022
    Perez-Concha O; Goldstein D; Harris MF; Laaksonen MA; Hanly M; Suchy S; Vajdic CM, 2022, 'Uptake of Team Care Arrangements for adults newly diagnosed with cancer', Australian Journal of Primary Health, vol. 29, http://dx.doi.org/10.1071/py22078
    Journal articles | 2022
    Siu DHW; Ali A; Tjokrowidjaja A; De Silva M; Lee J; Clingan PR; Aghmesheh M; Brungs D; Mapagu C; Goldstein D; O'Neill S; Liauw WS; Sjoquist KM; Thomas D; Pavlakis N; Clarke SJ; Diakos C; Chantrill LA, 2022, 'Clinical and molecular profile of young adults with early-onset colorectal cancer: Experience from four Australian tertiary centers', Asia-Pacific Journal of Clinical Oncology, vol. 18, pp. 660 - 668, http://dx.doi.org/10.1111/ajco.13745
    Journal articles | 2022
    Sjoquist KM; Martin A; Pavlakis N; Goldstein D; Tsobanis E; Moses D; Maher R; Hague W; Gebski V; Stockler MR; Simes RJ, 2022, 'Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer', Journal of Cancer Research and Clinical Oncology, http://dx.doi.org/10.1007/s00432-022-04404-4
    Journal articles | 2022
    Timmins HC; Li T; Goldstein D; Trinh T; Mizrahi D; Harrison M; Horvath LG; Friedlander M; Kiernan MC; Park SB, 2022, 'The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors', Journal of Cancer Survivorship, vol. 16, pp. 223 - 232, http://dx.doi.org/10.1007/s11764-021-01012-y
    Journal articles | 2021
    Aughton K; Elander NO; Evans A; Jackson R; Campbell F; Costello E; Halloran CM; Mackey JR; Scarfe AG; Valle JW; Carter R; Cunningham D; Tebbutt NC; Goldstein D; Shannon J; Glimelius B; Hackert T; Charnley RM; Anthoney A; Lerch MM; Mayerle J; Palmer DH; Büchler MW; Ghaneh P; Neoptolemos JP; Greenhalf W, 2021, 'HENT1 predicts benefit from gemcitabine in pancreatic cancer but only with low CDA mRNA', Cancers, vol. 13, http://dx.doi.org/10.3390/cancers13225758
    Journal articles | 2021
    Battaglini E; Goldstein D; Grimison P; McCullough S; Mendoza-Jones P; Park SB, 2021, 'Chemotherapy-induced peripheral neurotoxicity in cancer survivors: Predictors of long-term patient outcomes', JNCCN Journal of the National Comprehensive Cancer Network, vol. 19, pp. 821 - 828, http://dx.doi.org/10.6004/jnccn.2021.7026
    Journal articles | 2021
    Butow P; Müller F; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub TE; Thomas DM; Goldstein D; Best MC; Newson A; Tucker K; Vines R; Vines K; Kirk J; Young MA; Savard J; Jacobs C, 2021, 'Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling', Psycho-Oncology, vol. 30, pp. 1920 - 1929, http://dx.doi.org/10.1002/pon.5764
    Journal articles | 2021
    Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Penel N; Hartmann JT; Duffaud F; Goldstein D; Martin-Broto J; Gronchi A; Wardelmann E; Marréaud S; Zalcberg JR; Litière S; Blay JY, 2021, 'Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)', Annals of Oncology, vol. 32, pp. 533 - 541, http://dx.doi.org/10.1016/j.annonc.2021.01.004
    Journal articles | 2021
    Chiang JCB; Goldstein D; Park SB; Krishnan AV; Markoulli M, 2021, 'Corneal nerve changes following treatment with neurotoxic anticancer drugs', Ocular Surface, vol. 21, pp. 221 - 237, http://dx.doi.org/10.1016/j.jtos.2021.06.007
    Journal articles | 2021
    Chiang JCB; Goldstein D; Tavakoli A; Trinh T; Klisser J; Lewis CR; Friedlander M; Naduvilath TJ; Au K; Park SB; Krishnan AV; Markoulli M, 2021, 'Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxel', Scientific Reports, vol. 11, http://dx.doi.org/10.1038/s41598-021-02439-0
    Journal articles | 2021
    Chiang JCB; Goldstein D; Trinh T; Au K; Mizrahi D; Muhlmann M; Crowe P; O’neill S; Edwards K; Park SB; Krishnan AV; Markoulli M, 2021, 'A cross-sectional study of sub-basal corneal nerve reduction following neurotoxic chemotherapy', Translational Vision Science and Technology, vol. 10, pp. 1 - 11, http://dx.doi.org/10.1167/tvst.10.1.24
    Journal articles | 2021
    Chiang JCB; Goldstein D; Trinh T; Au K; Park SB; Krishnan AV; Markoulli M, 2021, 'A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer', Scientific Reports, vol. 11, pp. 1786, http://dx.doi.org/10.1038/s41598-021-81398-y
    Journal articles | 2021
    Clifford BK; Jones MD; Simar D; Barry BK; Goldstein D, 2021, 'The effect of exercise intensity on exercise-induced hypoalgesia in cancer survivors: A randomized crossover trial', Physiological Reports, vol. 9, pp. e15047, http://dx.doi.org/10.14814/phy2.15047
    Journal articles | 2021
    Giraud P; Racadot S; Vernerey D; Goldstein D; Glimelius B; Van Houtte P; Gubanski M; Spry N; Van Laethem JL; Hammel P; Huguet F, 2021, 'Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma', International Journal of Radiation Oncology Biology Physics, vol. 110, pp. 993 - 1002, http://dx.doi.org/10.1016/j.ijrobp.2021.01.055
    Journal articles | 2021
    Kokkinos J; Ignacio RM; Haghighi K; Kopecky C; Sharbeen G; Gonzales-Aloy E; Youkhana J; Butler L; Goldstein D; McCarroll J; Phillips P, 2021, 'Patient-derived pancreatic tumours in a dish: implications for real-time precision medicine', HPB, vol. 23, pp. S235 - S235, http://dx.doi.org/10.1016/j.hpb.2020.11.590
    Journal articles | 2021
    Kokkinos J; Jensen A; Sharbeen G; McCarroll JA; Goldstein D; Haghighi KS; Phillips PA, 2021, 'Does the microenvironment hold the hidden key for functional precision medicine in pancreatic cancer?', Cancers, vol. 13, pp. 2427 - 2427, http://dx.doi.org/10.3390/cancers13102427
    Journal articles | 2021
    Kokkinos J; Sharbeen G; Haghighi KS; Ignacio RMC; Kopecky C; Gonzales-Aloy E; Youkhana J; Timpson P; Pereira BA; Ritchie S; Pandzic E; Boyer C; Davis TP; Butler LM; Goldstein D; McCarroll JA; Phillips PA, 2021, 'Ex vivo culture of intact human patient derived pancreatic tumour tissue', Scientific Reports, vol. 11, pp. 1944, http://dx.doi.org/10.1038/s41598-021-81299-0
    Journal articles | 2021
    Lees JG; Abdulla M; Barkl-Luke ME; Livni L; Keating BA; Hayes J; Fiore NT; Park SB; Moalem-Taylor G; Goldstein D, 2021, 'Effect of exercise on neuromuscular toxicity in oxaliplatin-treated mice', Muscle and Nerve, vol. 64, pp. 225 - 234, http://dx.doi.org/10.1002/mus.27329
    Journal articles | 2021
    Li T; Mizrahi D; Goldstein D; Kiernan MC; Park SB, 2021, 'Chemotherapy and peripheral neuropathy', Neurological Sciences, vol. 42, pp. 4109 - 4121, http://dx.doi.org/10.1007/s10072-021-05576-6
    Journal articles | 2021
    Lundy J; Harris M; Zalcberg J; Zimet A; Goldstein D; Gebski V; Borsaru A; Desmond C; Swan M; Jenkins BJ; Croagh D, 2021, 'EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy', Frontiers in Oncology, vol. 11, http://dx.doi.org/10.3389/fonc.2021.770022
    Journal articles | 2021
    Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB, 2021, 'Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy', Gait and Posture, vol. 89, pp. 178 - 185, http://dx.doi.org/10.1016/j.gaitpost.2021.07.010
    Journal articles | 2021
    Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D, 2021, 'Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy', JAMA network open, vol. 4, pp. e2036695, http://dx.doi.org/10.1001/jamanetworkopen.2020.36695
    Journal articles | 2021
    Oar A; Lee M; Le H; Wilson K; Aiken C; Chantrill L; Simes J; Nguyen N; Barbour A; Samra J; Sjoquist KM; Moore A; Espinoza D; Gebski V; Yip S; Chu J; Kneebone A; Goldstein D, 2021, 'AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer', BMC Cancer, vol. 21, http://dx.doi.org/10.1186/s12885-021-08666-y
    Journal articles | 2021
    Pang TCY; Xu Z; Mekapogu AR; Pothula S; Becker T; Corley S; Wilkins MR; Goldstein D; Pirola R; Wilson J; Apte M, 2021, 'Hgf/c-met inhibition as adjuvant therapy improves outcomes in an orthotopic mouse model of pancreatic cancer', Cancers, vol. 13, http://dx.doi.org/10.3390/cancers13112763
    Journal articles | 2021
    Schernberg A; Vernerey D; Goldstein D; Van Laethem JL; Glimelius B; van Houtte P; Bonnetain F; Louvet C; Hammel P; Huguet F, 2021, 'Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma', International Journal of Radiation Oncology Biology Physics, vol. 110, pp. 1022 - 1031, http://dx.doi.org/10.1016/j.ijrobp.2021.01.052
    Journal articles | 2021
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2021, 'Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to slc7a11 inhibition', Cancer Research, vol. 81, pp. 3461 - 3479, http://dx.doi.org/10.1158/0008-5472.CAN-20-2496
    Journal articles | 2021
    Smit AK; Bartley N; Best MC; Napier CE; Butow P; Newson AJ; Tucker K; Ballinger ML; Thomas DM; Jacobs C; Meiser B; Goldstein D; Savard J; Juraskova I, 2021, 'Family communication about genomic sequencing: A qualitative study with cancer patients and relatives', Patient Education and Counseling, vol. 104, pp. 944 - 952, http://dx.doi.org/10.1016/j.pec.2020.10.022
    Journal articles | 2021
    Taggart J; Chin M; Liauw W; Goldstein D; Dolezal A; Plahn J; Harris MF, 2021, 'Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practice', Public Health Research and Practice, vol. 31, http://dx.doi.org/10.17061/PHRP31122108
    Journal articles | 2021
    Tempero M; O'Reilly E; Van Cutsem E; Berlin J; Philip P; Goldstein D; Tabernero J; Borad M; Bachet J; Parner V; Tebbutt N; Chua Y; Corrie P; Harris M; Taieb J; Burge M; Kunzmann V; Zhang G; McGovern D; Marks H; Biankin A; Reni M, 2021, 'LBA-1 Phase 3 APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) vs gemcitabine (Gem) alone in patients with resected pancreatic cancer (PC): Updated 5-year overall survival', Annals of Oncology, vol. 32, pp. S226 - S226, http://dx.doi.org/10.1016/j.annonc.2021.06.009
    Journal articles | 2021
    Timmins HC; Li T; Trinh T; Kiernan MC; Harrison M; Boyle F; Friedlander M; Goldstein D; Park SB, 2021, 'Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response', Oncologist, vol. 26, pp. 366 - 374, http://dx.doi.org/10.1002/onco.13697
    Journal articles | 2021
    Trinh T; Park SB; Murray J; Pickering H; Lin CSY; Martin A; Friedlander M; Kiernan MC; Goldstein D; Krishnan AV, 2021, 'Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy—a randomised controlled trial', Supportive Care in Cancer, vol. 29, pp. 1103 - 1110, http://dx.doi.org/10.1007/s00520-020-05591-x
    Journal articles | 2020
    Barbour AP; Samra JS; Haghighi KS; Donoghoe MW; Burge M; Harris MT; Chua YJ; Mitchell J; O’Rourke N; Chan H; Gebski VJ; Gananadha S; Croagh DG; Kench JG; Goldstein D; Barbour A; Goldstein D; Samra JS; Harris M; Chua YJ; Yip S; Simes J; Hicks R; Coates A; Gurney H; Do V; Marschner I; Goldstone S; Yip S; Pavlakis N; Goldstein D; Aghmesheh M; Joubert W; Grimes D; Burge M; Bagia S; Jaber M; Bryant R; Nathanson L; Cavallucci D; Fawcett J; O’Rourke T; Jones R, 2020, 'The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer', Annals of Surgical Oncology, vol. 27, pp. 2506 - 2515, http://dx.doi.org/10.1245/s10434-020-08205-2
    Journal articles | 2020
    Best MC; Butow P; Jacobs C; Savard J; Biesecker B; Ballinger ML; Bartley N; Davies G; Napier CE; Smit AK; Thomas DM; Newson AJ, 2020, 'Who should access germline genome sequencing? A mixed methods study of patient views', Clinical Genetics, vol. 97, pp. 329 - 337, http://dx.doi.org/10.1111/cge.13664
    Journal articles | 2020
    Butow P; Butow P; Davies G; Napier CE; Schlub T; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker B; Goldstein D; Thomas DM, 2020, 'Assessment of the Value of Tumor Variation Profiling Perceived by Patients with Cancer', JAMA Network Open, vol. 3, pp. e204721, http://dx.doi.org/10.1001/jamanetworkopen.2020.4721
    Journal articles | 2020
    Chiang JCB; Zahari I; Markoulli M; Krishnan AV; Park SB; Semmler A; Goldstein D; Edwards K, 2020, 'The impact of anticancer drugs on the ocular surface', Ocular Surface, vol. 18, pp. 403 - 417, http://dx.doi.org/10.1016/j.jtos.2020.03.008
    Journal articles | 2020
    Goldstein D; Von Hoff DD; Chiorean EG; Reni M; Tabernero J; Ramanathan RK; Botteman M; Aly A; Margunato-Debay S; Lu B; Louis CU; McGovern D; Lee CK, 2020, 'Nomogram for Estimating Overall Survival in Patients with Metastatic Pancreatic Cancer', Pancreas, vol. 49, pp. 744 - 750, http://dx.doi.org/10.1097/MPA.0000000000001563
    Journal articles | 2020
    Gronchi A; Bonvalot S; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom HJ; Van Coevorden F; Penel N; Kopp HG; Duffaud F; Goldstein D; Broto JM; Wardelmann E; Marréaud S; Smithers M; Le Cesne A; Zaffaroni F; Litière S; Blay JY; Casali PG, 2020, 'Quality of surgery and outcome in localized gastrointestinal stromal tumors treated within an international intergroup randomized clinical trial of adjuvant imatinib', JAMA Surgery, vol. 155, pp. e200397, http://dx.doi.org/10.1001/jamasurg.2020.0397
    Journal articles | 2020
    Kokkinos J; Ignacio RMC; Sharbeen G; Boyer C; Gonzales-Aloy E; Goldstein D; McCarroll JA; Phillips PA, 2020, 'Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs', Biomaterials, vol. 240, pp. 119742, http://dx.doi.org/10.1016/j.biomaterials.2019.119742
    Journal articles | 2020
    Kokkinos J; Sharbeen G; Haghighi KS; Ignacio RMC; Kopecky C; Gonzales-Aloy E; Youkhana J; Pandzic E; Boyer C; Davis TP; Butler LM; Goldstein D; McCarroll JA; Phillips PA, 2020, 'Bringing the pancreas patient back to the bench: Ex vivo culture of intact human patient derived pancreatic tumour tissue', , http://dx.doi.org/10.1101/2020.07.30.223925
    Journal articles | 2020
    Lees JG; White D; Keating BA; Barkl-Luke ME; Makker PGS; Goldstein D; Moalem-Taylor G, 2020, 'Oxaliplatin-induced haematological toxicity and splenomegaly in mice', PLoS ONE, vol. 15, pp. e0238164, http://dx.doi.org/10.1371/journal.pone.0238164
    Journal articles | 2020
    Li T; Timmins HC; King T; Kiernan MC; Goldstein D; Park SB, 2020, 'Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials', Hematological Oncology, vol. 38, pp. 229 - 243, http://dx.doi.org/10.1002/hon.2706
    Journal articles | 2020
    Lim BT; Butow P; Sze ML; Girgis A; Jefford M; Goldstein D; Costa D, 2020, 'Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groups', Asia-Pacific Journal of Clinical Oncology, vol. 16, pp. 115 - 122, http://dx.doi.org/10.1111/ajco.13290
    Journal articles | 2020
    Makker PGS; White D; Lees JG; Parmar J; Goldstein D; Park SB; Howells J; Moalem-Taylor G, 2020, 'Acute changes in nerve excitability following oxaliplatin treatment in mice', Journal of Neurophysiology, vol. 124, pp. 232 - 244, http://dx.doi.org/10.1152/jn.00260.2020
    Journal articles | 2020
    Reni M; Riess H; O'Reilly EM; Reeves JA; Chiorean E; George TJ; Scheithauer W; Pascal A; Lerch M; Brenner WS; Ko Y-J; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin J; Biankin A; Tempero MA, 2020, 'Concordance between independent and investigator assessment of disease-free survival (DFS) in the APACT trial.', Journal of Clinical Oncology, vol. 38, pp. 4618 - 4618, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.4618
    Journal articles | 2020
    Timmins HC; Li T; Huynh W; Kiernan MC; Baron-Hay S; Boyle F; Goldstein D; Park SB, 2020, 'Electrophysiological and phenotypic profiles of taxane-induced neuropathy', Clinical Neurophysiology, vol. 131, pp. 1979 - 1985, http://dx.doi.org/10.1016/j.clinph.2020.02.028
    Journal articles | 2020
    Timmins HC; Li T; Kiernan MC; Baron-Hay S; Marx G; Boyle F; Goldstein D; Park SB, 2020, 'Taxane-induced peripheral neuropathy: differences in patient report and objective assessment', Supportive Care in Cancer, vol. 28, pp. 4459 - 4466, http://dx.doi.org/10.1007/s00520-020-05299-y
    Journal articles | 2020
    Timmins HC; Li T; Kiernan MC; Horvath LG; Goldstein D; Park SB, 2020, 'Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients', Journal of Pain, vol. 21, pp. 44 - 58, http://dx.doi.org/10.1016/j.jpain.2019.06.011
    Journal articles | 2020
    Tjokrowidjaja A; Goldstein D; Hudson HM; Lord SJ; Gebski V; Clarke S; de Souza P; Motzer RJ; Lee CK, 2020, 'The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy', Acta Oncologica, vol. 59, pp. 20 - 27, http://dx.doi.org/10.1080/0284186X.2019.1656342
    Journal articles | 2020
    Wang X; Yeo RX; Hogg PJ; Goldstein D; Crowe P; Dilda PJ; Yang JL, 2020, 'The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas', Oncotarget, vol. 11, pp. 46 - 61, http://dx.doi.org/10.18632/oncotarget.27416
    Journal articles | 2019
    Best MC; Bartley N; Jacobs C; Juraskova I; Goldstein D; Newson AJ; Savard J; Meiser B; Ballinger M; Napier C; Thomas D; Biesecker B; Butow P; Tucker K; Schlub T; Vines R; Vines K; Kirk J; Young MA, 2019, 'Patient perspectives on molecular tumor profiling: "why wouldn't you?"', BMC Cancer, vol. 19, pp. 753, http://dx.doi.org/10.1186/s12885-019-5920-x
    Journal articles | 2019
    Kaur R; Meiser B; Zilliacus E; Tim Wong WK; Woodland L; Watts K; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda SK; Shaw T; Tebble H; Norris C; Goldstein D, 2019, 'Evaluation of an online communication skills training programme for oncology nurses working with patients from minority backgrounds', Supportive Care in Cancer, vol. 27, pp. 1951 - 1960, http://dx.doi.org/10.1007/s00520-018-4507-4
    Journal articles | 2019
    Lee B; Lipton L; Cohen J; Tie J; Javed AA; Li L; Goldstein D; Burge M; Cooray P; Nagrial A; Tebbutt NC; Thomson B; Nikfarjam M; Harris M; Haydon A; Lawrence B; Tai DWM; Simons K; Lennon AM; Wolfgang CL; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P, 2019, 'Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer', Annals of Oncology, vol. 30, pp. 1472 - 1478, http://dx.doi.org/10.1093/annonc/mdz200
    Journal articles | 2019
    Lim BT; Butow P; Mills J; Miller A; Pearce A; Goldstein D, 2019, 'Challenges and perceived unmet needs of Chinese migrants affected by cancer: Focus group findings', Journal of Psychosocial Oncology, vol. 37, pp. 383 - 397, http://dx.doi.org/10.1080/07347332.2018.1551261
    Journal articles | 2019
    Livni L; Lees JG; Barkl-Luke ME; Goldstein D; Moalem-Taylor G, 2019, 'Dorsal root ganglion explants derived from chemotherapy-treated mice have reduced neurite outgrowth in culture', Neuroscience Letters, vol. 694, pp. 14 - 19, http://dx.doi.org/10.1016/j.neulet.2018.11.016
    Journal articles | 2019
    Maharaj AD; Holland JF; Scarborough RO; Evans SM; Ioannou LJ; Brown W; Croagh DG; Pilgrim CHC; Kench JG; Lipton LR; Leong T; McNeil JJ; Nikfarjam M; Aly A; Burton PR; Cashin PA; Chu J; Duong CP; Evans P; Goldstein D; Haydon A; Hii MW; Knowles BPF; Merrett ND; Michael M; Neale RE; Philip J; Porter IWT; Smith M; Spillane J; Tagkalidis PP; Zalcberg JR, 2019, 'The Upper Gastrointestinal Cancer Registry (UGICR): A clinical quality registry to monitor and improve care in upper gastrointestinal cancers', BMJ Open, vol. 9, pp. e031434, http://dx.doi.org/10.1136/bmjopen-2019-031434
    Journal articles | 2019
    McCrary JM; Goldstein D; Sandler CX; Barry BK; Marthick M; Timmins HC; Li T; Horvath L; Grimison P; Park SB, 2019, 'Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, vol. 27, pp. 3849 - 3857, http://dx.doi.org/10.1007/s00520-019-04680-w
    Journal articles | 2019
    McCrary JM; Goldstein D; Trinh T; Timmins HC; Li T; Friedlander M; Bosco A; Harrison M; Maier N; O'Neill S; Park SB, 2019, 'Optimizing Clinical Screening for Chemotherapy-Induced Peripheral Neuropathy', Journal of Pain and Symptom Management, vol. 58, pp. 1023 - 1032, http://dx.doi.org/10.1016/j.jpainsymman.2019.07.021
    Journal articles | 2019
    McCrary JM; Goldstein D; Trinh T; Timmins HC; Li T; Menant J; Friedlander M; Lewis CR; Hertzberg M; O'Neill S; King T; Bosco A; Harrison M; Park SB, 2019, 'Balance deficits and functional disability in cancer survivors exposed to neurotoxic cancer treatments', JNCCN Journal of the National Comprehensive Cancer Network, vol. 17, pp. 949 - 955, http://dx.doi.org/10.6004/jnccn.2019.7290
    Journal articles | 2019
    McCrary JM; Goldstein D; Wyld D; Henderson R; Lewis CR; Park SB, 2019, 'Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test', Journal of Cancer Survivorship, vol. 13, pp. 495 - 502, http://dx.doi.org/10.1007/s11764-019-00769-7
    Journal articles | 2019
    Reni M; Riess H; O'Reilly E; Santoro A; Park J; Bekaii-Saab T; Tempero M; Shan Y; Macarulla T; Van Cutsem E; Noel M; Berlin J; Biankin A; Dhani N; Frassineti G; Goldstein D; Romano A; Bruchec YL; Philip P, 2019, 'An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 30, pp. iv126, http://dx.doi.org/10.1093/annonc/mdz154
    Journal articles | 2019
    Reni M; Winter J; Tortora G; Pelzer U; Riess H; Chang H; O'Reilly E; Oh D; Diaz IA; Milella M; Bendell J; Garlipp B; Tempero M; Macarulla T; Van Cutsem E; Berlin J; Goldstein D; Lu B; Jeanes J; Philip P, 2019, 'Analysis of patient screening in the phase III, international, randomized, open-label APACT trial', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 30, pp. iv110, http://dx.doi.org/10.1093/annonc/mdz156
    Journal articles | 2019
    Sclafani F; Hesselberg G; Thompson SR; Truskett P; Haghighi K; Rao S; Goldstein D, 2019, 'Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review', Journal of Surgical Oncology, vol. 119, pp. 489 - 496, http://dx.doi.org/10.1002/jso.25320
    Journal articles | 2019
    Sonbol MB; Ahn DH; Goldstein D; Okusaka T; Tabernero J; Macarulla T; Reni M; Li CP; O'Neil B; Van Cutsem E; Bekaii-Saab T, 2019, 'CanStem111P trial: A Phase III study of napabucasin plus nab-paclitaxel with gemcitabine', Future Oncology, vol. 15, pp. 1295 - 1302, http://dx.doi.org/10.2217/fon-2018-0903
    Journal articles | 2019
    Tan AC; McCrary JM; Park SB; Trinh T; Goldstein D, 2019, 'Chemotherapy-induced peripheral neuropathy—patient-reported outcomes compared with NCI-CTCAE grade', Supportive Care in Cancer, vol. 27, pp. 4771 - 4777, http://dx.doi.org/10.1007/s00520-019-04781-6
    Journal articles | 2019
    Tang M; Chen J; Goldstein D; Links M; Lord S; Marschner I; Simes RJ; Lee CK, 2019, 'Evaluation of Phase II Trial Design in Advanced Pancreatic Cancer', Pancreas, vol. 48, pp. 1274 - 1284, http://dx.doi.org/10.1097/MPA.0000000000001429
    Journal articles | 2019
    Tempero MA; Reni M; Riess H; O’Reilly EM; Krishnamurthi S; Österlund P; Ales-Diaz IC; Milella M; Siena S; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin JD; Li M; Ferrara S; Bruchec YL; McGovern D; Biankin A, 2019, 'Phase III, international, multicenter, randomized, open-label trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) alone for surgically resected pancreatic adenocarcinoma (APACT): Subgroup analyses', Annals of Oncology, vol. 30, pp. v259 - v260, http://dx.doi.org/10.1093/annonc/mdz247.010
    Journal articles | 2019
    Tempero MA; Reni M; Riess H; Pelzer U; O'Reilly EM; Winter JM; Oh D-Y; Li C-P; Tortora G; Chang H-M; Lopez CD; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin J; Ferrara S; Li M; Lu BD; Biankin A, 2019, 'APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma.', Journal of Clinical Oncology, vol. 37, pp. 4000 - 4000, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.4000
    Journal articles | 2019
    Vasista A; Stockler M; Martin A; Pavlakis N; Sjoquist K; Goldstein D; Gill S; Jain V; Liu G; Kannourakis G; Kim YH; Nott L; Snow S; Burge M; Harris D; Jonker D; Chua YJ; Epstein R; Bonaventura A; Kiely B, 2019, 'Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer', Oncologist, vol. 24, pp. e1102 - e1107, http://dx.doi.org/10.1634/theoncologist.2018-0613
    Journal articles | 2018
    Bekaii-Saab T; Okusaka T; Goldstein D; O'Neill B; Tabernero J; Li C; Reni M; Jin B; Oh C; Borodyansky L; Van Cutsem E, 2018, 'CanStem111P trial: A Phase 3 Study of napabucasin (NAPA) plus nab-paclitaxel (nPTX) with gemcitabine (Gem) in adult patients with metastatic pancreatic adenocarcinoma (mPDAC) - Trial in progress', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. v51 - v52, http://dx.doi.org/10.1093/annonc/mdy151.183
    Journal articles | 2018
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P, 2018, 'The PiGeOn project: Protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer', BMC Cancer, vol. 18, http://dx.doi.org/10.1186/s12885-018-4366-x
    Journal articles | 2018
    Clifford BK; Mizrahi D; Sandler CX; Barry BK; Simar D; Wakefield CE; Goldstein D, 2018, 'Barriers and facilitators of exercise experienced by cancer survivors: a mixed methods systematic review', Supportive Care in Cancer, vol. 26, pp. 685 - 700, http://dx.doi.org/10.1007/s00520-017-3964-5
    Journal articles | 2018
    Feather CE; Lees JG; Makker PGS; Goldstein D; Kwok JB; Moalem-Taylor G; Polly P, 2018, 'Oxaliplatin induces muscle loss and muscle-specific molecular changes in Mice', Muscle and Nerve, vol. 57, pp. 650 - 658, http://dx.doi.org/10.1002/mus.25966
    Journal articles | 2018
    Kandula T; Farrar MA; Krishnan AV; Murray J; Timmins HC; Goldstein D; Lin CSY; Kiernan MC; Park SB, 2018, 'Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy', Muscle and Nerve, vol. 57, pp. 615 - 621, http://dx.doi.org/10.1002/mus.25968
    Journal articles | 2018
    Martin AJ; Gibbs E; Sjoquist K; Pavlakis N; Simes J; Price T; Shannon J; Gill S; Jain V; Liu G; Kannourakis G; Kim YH; Kim JW; Goldstein D, 2018, 'Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma', Gastric Cancer, vol. 21, pp. 473 - 480, http://dx.doi.org/10.1007/s10120-017-0754-1
    Journal articles | 2018
    Thompson SR; Lee ISY; Carroll S; Bishop S; Douglas P; Lam F; Brown C; Williams J; Goldstein D, 2018, 'Radiotherapy for anal squamous cell carcinoma: must the upper pelvic nodes and the inguinal nodes be treated?', ANZ Journal of Surgery, vol. 88, pp. 870 - 875, http://dx.doi.org/10.1111/ans.14398
    Journal articles | 2018
    Wang X; Goldstein D; Crowe PJ; Yang JL, 2018, 'Antitumour effects and mechanisms of action of the panHER inhibitor, dacomitinib, alone and in combination with the STAT3 inhibitor, S3I-201, in human sarcoma cell lines', International Journal of Oncology, vol. 52, pp. 2143 - 2154, http://dx.doi.org/10.3892/ijo.2018.4337
    Journal articles | 2017
    Kandula T; Farrar MA; Kiernan MC; Krishnan AV; Goldstein D; Horvath L; Grimison P; Boyle F; Baron-Hay S; Park SB, 2017, 'Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer', Clinical Neurophysiology, vol. 128, pp. 1166 - 1175, http://dx.doi.org/10.1016/j.clinph.2017.04.009
    Journal articles | 2017
    Lees JG; Makker PGS; Tonkin RS; Abdulla M; Park SB; Goldstein D; Moalem-Taylor G, 2017, 'Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy', European Journal of Cancer, vol. 73, pp. 22 - 29, http://dx.doi.org/10.1016/j.ejca.2016.12.006
    Journal articles | 2017
    Lim BT; Butow P; Mills J; Miller A; Goldstein D, 2017, 'Information needs of the Chinese community affected by cancer: A systematic review', Psycho-Oncology, vol. 26, pp. 1433 - 1443, http://dx.doi.org/10.1002/pon.4347
    Journal articles | 2017
    Makker PGS; Duffy SS; Lees JG; Perera CJ; Tonkin RS; Butovsky O; Park SB; Goldstein D; Moalem-Taylor G, 2017, 'Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0170814
    Journal articles | 2017
    McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S; Horvath L; Park SB, 2017, 'Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey', Supportive Care in Cancer, vol. 25, pp. 3485 - 3493, http://dx.doi.org/10.1007/s00520-017-3772-y
    Journal articles | 2017
    Pang TCY; Xu Z; Pothula S; Becker T; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2017, 'Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research', Carcinogenesis, vol. 38, pp. 588 - 591, http://dx.doi.org/10.1093/carcin/bgx030
    Journal articles | 2017
    Sandler CX; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; segelov E; Boyle FM; Chin MT; webber K; Barry BK; Lloyd AR, 2017, 'Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue.', Journal of Pain and Symptom Management, vol. 54, pp. 74 - 84, http://dx.doi.org/10.1016/j.jpainsymman.2017.03.015
    Journal articles | 2017
    Segelov E; Lordick F; Goldstein D; Chantrill LA; Croagh D; Lawrence B; Arnold D; Chau I; Obermannova R; Price TJ, 2017, 'Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty', Expert Review of Anticancer Therapy, vol. 17, pp. 951 - 964, http://dx.doi.org/10.1080/14737140.2017.1369882
    Journal articles | 2017
    Watts KJ; Meiser B; Zilliacus E; Kaur R; Taouk M; Girgis A; Butow P; Goldstein D; Hale S; Perry A; Aranda SK; Kissane DW, 2017, 'Communicating with patients from minority backgrounds: Individual challenges experienced by oncology health professionals', European Journal of Oncology Nursing, vol. 26, pp. 83 - 90, http://dx.doi.org/10.1016/j.ejon.2016.12.001
    Journal articles | 2017
    Watts KJ; Meiser B; Zilliacus E; Kaur R; Taouk M; Girgis A; Butow P; Kissane D; Hale S; Perry A; Aranda SK; Goldstein D, 2017, 'Perspectives of oncology nurses and oncologists regarding barriers to working with patients from a minority background: systemic issues and working with interpreters.', European Journal of Cancer Care, vol. 27, pp. e12758, http://dx.doi.org/10.1111/ecc.12758
    Journal articles | 2016
    Beesley VL; Janda M; Goldstein D; Gooden H; Merrett ND; O'Connell DL; Rowlands IJ; Wyld D; Neale RE, 2016, 'A tsunami of unmet needs: Pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services', Psycho-Oncology, vol. 25, pp. 150 - 157, http://dx.doi.org/10.1002/pon.3887
    Journal articles | 2016
    Bridgewater J; Lopes A; Wasan H; Malka D; Jensen L; Okusaka T; Knox J; Wagner D; Cunningham D; Shannon J; Goldstein D; Moehler M; Bekaii-Saab T; McNamara MG; Valle JW, 2016, 'Prognostic factors for progression-free and overall survival in advanced biliary tract cancer', Annals of Oncology, vol. 27, pp. 134 - 140, http://dx.doi.org/10.1093/annonc/mdv483
    Journal articles | 2016
    Chiorean EG; Von Hoff DD; Reni M; Arena FP; Infante JR; Bathini VG; Wood TE; Mainwaring PN; Muldoon RT; Clingan PR; Kunzmann V; Ramanathan RK; Tabernero J; Goldstein D; McGovern D; Lu B; Ko A, 2016, 'CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer', Annals of Oncology, vol. 27, pp. 654 - 660, http://dx.doi.org/10.1093/annonc/mdw006
    Journal articles | 2016
    Gandy RC; Barbour AP; Samra J; Nikfarjam M; Haghighi K; Kench JG; Saxena P; Goldstein D, 2016, 'Refining the care of patients with pancreatic cancer: The AGITG Pancreatic Cancer Workshop consensus', Medical Journal of Australia, vol. 204, pp. 419 - 422.e1, http://dx.doi.org/10.5694/mja16.00061
    Journal articles | 2016
    Goldstein D; Rosenberg JE; Figlin RA; Townsend RR; McCann L; Carpenter C; Pandite L, 2016, 'Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?', European Journal of Cancer, vol. 53, pp. 96 - 104, http://dx.doi.org/10.1016/j.ejca.2015.10.006
    Journal articles | 2016
    Goldstein D; Von Hoff DD; Moore M; Greeno E; Tortora G; Ramanathan RK; Macarulla T; Liu H; Pilot R; Ferrara S; Lu B, 2016, 'Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)', European Journal of Cancer, vol. 52, pp. 85 - 91, http://dx.doi.org/10.1016/j.ejca.2015.10.017
    Journal articles | 2016
    Hammel P; Huguet F; Van Laethem JL; Goldstein D; Glimelius B; Artru P; Borbath I; Bouché O; Shannon J; André T; Mineur L; Chibaudel B; Bonnetain F; Louvet C, 2016, 'Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib the LAP07 randomized clinical trial', JAMA - Journal of the American Medical Association, vol. 315, pp. 1844 - 1853, http://dx.doi.org/10.1001/jama.2016.4324
    Journal articles | 2016
    He EYJ; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: An Australian population-based multicenter study', Oncologist, vol. 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530
    Journal articles | 2016
    Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA, 2016, 'Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge', Cancer Treatment Reviews, vol. 50, pp. 118 - 128, http://dx.doi.org/10.1016/j.ctrv.2016.09.005
    Journal articles | 2016
    McCarroll JA; Teo J; Boyer C; Youkhana J; Sagnella S; Duong H; Sharbeen G; Goldstein D; Davis T; Kavallaris M; Phillips P; Liu J, 2016, 'A rationally optimized nanoparticle system for the delivery of RNA interference therapeutics into pancreatic tumors in vivo.', Biomacromolecules, vol. 17, pp. 2337 - 2351, http://dx.doi.org/10.1021/acs.biomac.6b00185
    Journal articles | 2016
    O’Callaghan C; Schofield P; Butow P; Nolte L; Price M; Tsintziras S; Sze M; Thein T; Yiu D; Mireskandari S; Goldstein D; Jefford M, 2016, '“I might not have cancer if you didn’t mention it”: a qualitative study on information needed by culturally diverse cancer survivors', Supportive Care in Cancer, vol. 24, pp. 409 - 418, http://dx.doi.org/10.1007/s00520-015-2811-9
    Journal articles | 2016
    Pavlakis N; Sjoquist KM; Martin AJ; Tsobanis E; Yip S; Kang YK; Bang YJ; Alcindor T; O'Callaghan CJ; Burnell MJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Wong M; Strickland A; Kim JW; Zalcberg JR; Simes J; Goldstein D, 2016, 'Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial', Journal of Clinical Oncology, vol. 34, pp. 2728 - 2735, http://dx.doi.org/10.1200/JCO.2015.65.1901
    Journal articles | 2016
    Ramanathan RK; Goldstein D; Korn RL; Arena F; Moore M; Siena S; Teixeira L; Tabernero J; Van Laethem JL; Liu H; McGovern D; Lu B; Von Hoff DD, 2016, 'Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas', Annals of Oncology, vol. 27, pp. 648 - 653, http://dx.doi.org/10.1093/annonc/mdw020
    Journal articles | 2016
    Reichardt P; Demetri GD; Gelderblom H; Rutkowski P; Im SA; Gupta S; Kang YK; Schöffski P; Schuette J; Soulières D; Blay JY; Goldstein D; Fly K; Huang X; Corsaro M; Lechuga MJ; Martini JF; Heinrich MC, 2016, 'Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial', BMC Cancer, vol. 16, http://dx.doi.org/10.1186/s12885-016-2051-5
    Journal articles | 2016
    Shaw JM; Shepherd HL; Durcinoska I; Butow PN; Liauw W; Goldstein D; Young JM, 2016, 'It’s all good on the surface: care coordination experiences of migrant cancer patients in Australia', Supportive Care in Cancer, vol. 24, pp. 2403 - 2410, http://dx.doi.org/10.1007/s00520-015-3043-8
    Journal articles | 2016
    Wang X; Goldstein D; Crowe PJ; Yang JL, 2016, 'Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: A review of the evidence', OncoTargets and Therapy, vol. 9, pp. 5461 - 5473, http://dx.doi.org/10.2147/OTT.S94745
    Journal articles | 2015
    Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Adenis A; Hartmann JT; Duffaud F; Goldstein D; Broto JM; Gronchi A; Dei Tos AP; Marréaud S; Van Der Graaf WTA; Zalcberg JR; Litière S; Blay JY, 2015, 'Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas', Journal of Clinical Oncology, vol. 33, pp. 4276 - 4283, http://dx.doi.org/10.1200/JCO.2015.62.4304
    Journal articles | 2015
    Donskov F; Michaelson MD; Puzanov I; Davis MP; Bjarnason GA; Motzer RJ; Goldstein D; Lin X; Cohen DP; Wiltshire R; Rini BI, 2015, 'Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients', British Journal of Cancer, vol. 113, pp. 1571 - 1580, http://dx.doi.org/10.1038/bjc.2015.368
    Journal articles | 2015
    Goldstein D; El-Maraghi RH; Hammel P; Heinemann V; Kunzmann V; Sastre J; Scheithauer W; Siena S; Tabernero J; Teixeira L; Tortora G; Van Laethem JL; Young R; Penenberg DN; Lu B; Romano A; Von Hoff DD, 2015, 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: Long-term survival from a phase III trial', Journal of the National Cancer Institute, vol. 107, http://dx.doi.org/10.1093/jnci/dju413
    Journal articles | 2015
    Sandler C; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; Segelov E; Boyle FM; Chin MTM; Barry BK; Webber K; Lloyd AR, 2015, 'TOPS: A randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue.', Journal of Clinical Oncology, vol. 33, pp. 9571 - 9571, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.9571
    Journal articles | 2015
    Stein A; Arnold D; Bridgewater J; Goldstein D; Jensen LH; Klümpen HJ; Lohse AW; Nashan B; Primrose J; Schrum S; Shannon J; Vettorazzi E; Wege H, 2015, 'Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial', BMC Cancer, vol. 15, http://dx.doi.org/10.1186/s12885-015-1498-0
    Journal articles | 2015
    Sze M; Butow P; Bell M; Vaccaro L; Dong S; Eisenbruch M; Jefford M; Girgis A; King M; McGrane J; Ng W; Asghari R; Parente P; Liauw W; Goldstein D; Psycho-oncology Co-operative Research Group Culturally and Linguistically Diverse (CALD) TEAM , 2015, 'Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variables', Oncologist, vol. 20, pp. 523 - 531, http://dx.doi.org/10.1634/theoncologist.2014-0274
    Journal articles | 2015
    Tabernero J; Gabrielachiorean E; Infante JR; Hingorani SR; Ganju V; Weekes C; Scheithauer W; Ramanathan RK; Goldstein D; Penenberg DN; Romano A; Ferrara S; Von Hoff DD, 2015, 'Prognostic factorsofsurvival inarandomizedphaseIIItrial (MPACT)of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer', Oncologist, vol. 20, pp. 143 - 150, http://dx.doi.org/10.1634/theoncologist.2014-0394
    Journal articles | 2014
    Goldstein D; Bell ML; Butow P; Sze M; Vaccaro L; Dong S; Liauw W; Hui R; Tattersall M; Ng W; Asghari R; Steer C; Vardy J; Parente P; Harris M; Karanth NV; King M; Girgis A; Eisenbruch M; Jefford M, 2014, 'Immigrants' perceptions of the quality of their cancer care: An Australian comparative study, identifying potentially modifiable factors', Annals of Oncology, vol. 25, pp. 1643 - 1649, http://dx.doi.org/10.1093/annonc/mdu182
    Journal articles | 2014
    Greenhalf W; Ghaneh P; Neoptolemos JP; Palmer DH; Cox TF; Lamb RF; Garner E; Campbell F; MacKey JR; Costello E; Moore MJ; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Shannon J; Dervenis C; Glimelius B; Deakin M; Charnley RM; Lacaine F; Scarfe AG; Middleton MR; Anthoney A; Halloran CM; Mayerle J; Oláh A; Jackson R; Rawcliffe CL; Scarpa A; Bassi C; Büchler MW, 2014, 'Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial', Journal of the National Cancer Institute, vol. 106, http://dx.doi.org/10.1093/jnci/djt347
    Journal articles | 2014
    Hillman RJ; Garland SM; Gunathilake MPW; Stevens M; Kumaradevan N; Lemech C; Ward RL; Meagher A; McHugh L; Jin F; Carroll S; Goldstein D; Grulich AE; Tabrizi SN, 2014, 'Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers', International Journal of Cancer, vol. 135, pp. 996 - 1001, http://dx.doi.org/10.1002/ijc.28730
    Journal articles | 2014
    McCarroll J; Teo J; Boyer C; Goldstein D; Kavallaris M; Phillips PA, 2014, 'Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer', Frontiers in Physiology, vol. 5, pp. 1 - 10, http://dx.doi.org/10.3389/fphys.2014.00002
    Journal articles | 2014
    McGrane JA; Butow PN; Sze M; Eisenbruch M; Goldstein D; King MT, 2014, 'Assessing the invariance of a culturally competent multi-lingual unmet needs survey for immigrant and Australian-born cancer patients: a Rasch analysis', Quality of Life Research, http://dx.doi.org/10.1007/s11136-014-0717-5
    Journal articles | 2014
    Park SB; Kwok JB; Loy CT; Friedlander ML; Lin CSY; Krishnan AV; Lewis CR; Kiernan MC, 2014, 'Paclitaxel-induced neuropathy: Potential association of MAPT and GSK3B genotypes', BMC Cancer, vol. 14, http://dx.doi.org/10.1186/1471-2407-14-993
    Journal articles | 2014
    Von Hoff DD; Goldstein D; Renschler MF, 2014, 'The authors reply', New England Journal of Medicine, vol. 370, pp. 479 - 480, http://dx.doi.org/10.1056/NEJMc1314761
    Journal articles | 2014
    Wang X; Goldstein D; Crowe PJ; Yang JL, 2014, 'Impact of STAT3 inhibition on survival of osteosarcoma cell lines', Anticancer Research, vol. 34, pp. 6537 - 6545
    Journal articles | 2013
    Bell ML; Butow PN; Goldstein D, 2013, 'Informatively missing quality of life and unmet needs sex data for immigrant and Anglo-Australian cancer patients and survivors', Quality of Life Research, vol. 22, pp. 2757 - 2760, http://dx.doi.org/10.1007/s11136-013-0392-y
    Journal articles | 2013
    Butow PN; Aldridge L; Bell M; Sze M; Eisenbruch M; Jefford M; Schofield P; Girgis A; King M; Duggal-beri P; Goldstein D, 2013, 'Inferior health-related quality of life and psychological well-being in immigrant cancer survivors: A population-based study', European Journal of Cancer, vol. 49, pp. 1948 - 1956, http://dx.doi.org/10.1016/j.ejca.2013.01.011
    Journal articles | 2013
    Butow PN; Bell M; Aldridge L; Sze M; Eisenbruch M; Jefford M; Schofield P; Girgis A; King M; Duggal-beri P; McGrane J, 2013, 'Unmet needs in immigrant cancer survivors: a cross-sectional population-based study', Supportive Care in Cancer, vol. 21, pp. 2509 - 2520, http://dx.doi.org/10.1007/s00520-013-1819-2
    Journal articles | 2013
    Butow PN; Sze M; Eisenbruch M; Bell ML; Aldridge LJ; Abdo S; Tanious M; Dong S; Iedema R; Vardy J; Hui R; Boyle F; Liauw W; Goldstein D, 2013, 'Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients', Patient Education and Counseling, vol. 92, pp. 246 - 252, http://dx.doi.org/10.1016/j.pec.2013.03.006
    Journal articles | 2013
    Chou A; Waddell N; Cowley MJ; Gill AJ; Chang DK; Patch AM; Nones K; Wu J; Pinese M; Johns AL; Miller DK; Kassahn KS; Nagrial AM; Wasan H; Goldstein D; Toon CW; Chin V; Chantrill L; Humphris J; Mead RS; Rooman I; Samra JS; Pajic M; Musgrove EA; Pearson JV; Morey AL; Grimmond SM; Biankin AV, 2013, 'Clinical and molecular characterization of HER2 amplified-pancreatic cancer', Genome Medicine, vol. 5, http://dx.doi.org/10.1186/gm482
    Journal articles | 2013
    Grimison P; Phillips F; Butow P; White K; Yip D; Sardelic F; Underhill C; Tse R; Simes R; Turley K; Raymond C; Goldstein D, 2013, 'Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals', Asia-Pacific Journal of Clinical Oncology, vol. 9, pp. 226 - 238, http://dx.doi.org/10.1111/ajco.12014
    Journal articles | 2013
    Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, vol. 63, pp. 419 - 437, http://dx.doi.org/10.3322/caac.21204
    Journal articles | 2013
    Shaw J; Butow P; Sze M; Young J; Goldstein D, 2013, 'Reducing disparity in outcomes for immigrants with cancer: A qualitative assessment of the feasibility and acceptability of a culturally targeted telephone-based supportive care intervention', Supportive Care in Cancer, vol. 21, pp. 2297 - 2301, http://dx.doi.org/10.1007/s00520-013-1786-7
    Journal articles | 2013
    Short M; Goldstein D; Halkett G; Reece W; Borg M; Zissiadis Y; Kneebone A; Spry N, 2013, 'Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer', International Journal of Radiation Oncology Biology Physics, vol. 85, pp. 157 - 162, http://dx.doi.org/10.1016/j.ijrobp.2012.03.003
    Journal articles | 2013
    Tan K; Goldstein D; Crowe P; Yang JL, 2013, 'Uncovering a key to the process of metastasis in human cancers: A review of critical regulators of anoikis', Journal of Cancer Research and Clinical Oncology, vol. 139, pp. 1795 - 1805, http://dx.doi.org/10.1007/s00432-013-1482-5
    Journal articles | 2013
    Teo J; Erlich RB; Sagnella S; Dwarte T; Davis TP; Kavallaris M; McCarroll J; Boyer C; Duong HTT; Phillips P; Sharbeen G; Goldstein D, 2013, 'Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers', Molecular Pharmaceutics, vol. 10, pp. 2435 - 2444, http://dx.doi.org/10.1021/mp400049e
    Journal articles | 2012
    Butow PN; Philips F; Schweder J; White K; Underhill C; Goldstein D, 2012, 'Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review', Supportive Care in Cancer, vol. 20, pp. 1 - 22, http://dx.doi.org/10.1007/s00520-011-1270-1
    Journal articles | 2012
    Chua YJ; Karapetis CS; Underhill C; Nott LM; Goldstein D; Cronk MF; Gebski V; Wong N; Sjoquist KM; Biankin AV, 2012, 'PAN1: A randomized phase II study evaluating potential predictive biomarkers in the treatment of metastatic pancreatic cancer.', Journal of Clinical Oncology, vol. 30, pp. TPS4137 - TPS4137, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.tps4137
    Journal articles | 2012
    Clarke SJ; Yip S; Brown C; Van Hazel GA; Ransom DT; Goldstein D; Mark Jeffrey G; Tebbutt NC; Buck M; Lowenthal RM; Boland A; Gebski V; Zalcberg J; John Simes R, 2012, 'Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836))', European Journal of Cancer, vol. 48, pp. 407, http://dx.doi.org/10.1016/j.ejca.2011.12.001
    Journal articles | 2012
    Demetri GD; Garrett C; Sch offski P; Shah M; Verweij J; Leyvraz S; Hurwitz HI; Lopez Pousa A; Le Cesne A; Goldstein D; Paz-Ares L; Blay J; McArthur G; Xu Q; Huang X; Harmon CS; Tassell V; Cohen DP; Casali P, 2012, 'Complete Longitudinal Analyses of the Randomized,Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure', Clinical Cancer Research, vol. 18, pp. 3170 - 3179, http://dx.doi.org/10.1158/1078-0432.CCR-11-3005
    Journal articles | 2012
    Dumont AG; Rink L; Godwin AK; Miettinen M; Joensuu H; Strosberg JR; Gronchi A; Corless CL; Goldstein D; Rubin BP; Maki RG; Lazar AJ; Lev D; Trent JC; von Mehren M, 2012, 'A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients.', Annals of Oncology, vol. 23, pp. 1335 - 1340, http://dx.doi.org/10.1093/annonc/mdr442
    Journal articles | 2012
    Goldstein D; Bennett BK; Webber K; Boyle F; De Souza P; Wilcken NRC; Scott E; Toppler R; Murie P; O''Malley L; Mccourt J; Friedlander M; Hickie IB; Lloyd AR, 2012, 'Cancer-related fatigue in women with breast cancer: outcomes of a 5 year prospective cohort study.', Journal of Clinical Oncology, vol. 30, pp. 1805 - 1812, http://dx.doi.org/10.1200/JCO.2011.34.6148
    Journal articles | 2012
    Goldstein D; Spry N; Cummins MM; Brown C; Van Hazel GA; Carroll SL; Selva Nayagam S; Borg M; Ackland S; Wratten C; Shapiro J; Porter L; Hruby G; Horvath LG; Bydder S; Underhill C; Harvey JE; Gebski V, 2012, 'The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer', British Journal of Cancer, vol. 106, pp. 61 - 69, http://dx.doi.org/10.1038/bjc.2011.526
    Journal articles | 2012
    Grünwald V; Karakiewicz PI; Bavbek SE; Miller K; Machiels JP; Lee SH; Larkin J; Bono P; Rha SY; Castellano D; Blank CU; Knox JJ; Hawkins R; Anak O; Rosamilia M; Booth J; Pirotta N; Bodrogi I; Romedi M; Ferrandini S; Rondinon M; Pittman K; Goldstein D; Shapiro J; Troon S; Yip D; Mainwaring P; Zigeuner R; Loidl W; Greil RF; Schmidinger M; De Grève J; Rottey S; Vermorken J; Gil T; Gennigens C; Roumeguere T; Barrios C; Mathias C; Assi H; Hotte S; Karakiewicz P; Knox J; Spadafora S; Wood L; Zalewski P; Mackensie M; Bjarnason G; Lalancette A; Chan A; Higgins B; North S; Soulieres D; Asselah J; Sperlich C; Miller W; Yadav S; El-Maraghi R; Godoy J; Prausová J; Katolicka J; Petruzelka L; Kiss I; Lapela M; Miller K; Bergmann L; Beck J; Jäger E; Kindler M; Overkamp F; Wirth M; Hölzer W; Gschwend J; Stenzl A; Gauler T; Niederwieser D; Marschner N; Lück A; Tessen H; Eichelberg C; Steiner T; Goebell P; Kettner E; Bakhshandeh-Bath A; Wilhelm M; Schmitz S; Jacob A; Bierer S; Kube U; Staehler M; Engel E; Frambach M; Schellenberger U; Albers P; Simon J; Gleissler M; Klotz T; Repp R, 2012, 'An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy', European Journal of Cancer, vol. 48, pp. 324 - 332, http://dx.doi.org/10.1016/j.ejca.2011.06.054
    Journal articles | 2012
    Ngan SY; Burmeister B; Fisher R; Solomon M; Goldstein D; Joseph D; Ackland S; Schache D; McClure B; McLachlan S; McKendrick J; Leong T; Hartopeanu C; Zalcberg J; Mackay J, 2012, 'Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04', Journal of Clinical Oncology, vol. 30, pp. 3827 - 3833, http://dx.doi.org/10.1200/JCO.2012.42.9597
    Journal articles | 2012
    Wang X; Crowe PJ; Goldstein D; Yang JL, 2012, 'STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers', International Journal of Oncology, vol. 41, pp. 1181 - 1191, http://dx.doi.org/10.3892/ijo.2012.1568
    Journal articles | 2011
    Butow PN; Goldstein D; Bell ML; Sze M; Aldridge LJ; Abdo S; Tanious M; Dong S; Iedema R; Vardy J; Ashgari R; Hui R; Eisenbruch M, 2011, 'Interpretation in consultations with immigrant patients with cancer: How accurate is it?', Journal of Clinical Oncology, vol. 29, pp. 2801 - 2807, http://dx.doi.org/10.1200/JCO.2010.34.3335
    Journal articles | 2011
    Clarke SJ; Yip S; Brown C; Van Hazel GA; Ransom DT; Goldstein D; Jeffrey GM; Tebbutt NC; Buck M; Lowenthal RM; Boland A; Gebski V; Zalcberg J; Simes RJ, 2011, 'Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis', European Journal of Cancer, vol. 47, pp. 1826 - 1836, http://dx.doi.org/10.1016/j.ejca.2011.04.024
    Journal articles | 2011
    Goldstein D; Butow P; Sze M; Mikhail M; Eisenbruch M, 2011, 'Grappling with cultural differences; Communication between oncologists and immigrant cancer patients with and without interpreters', Patient Education and Counseling, vol. 84, pp. 398 - 405, http://dx.doi.org/10.1016/j.pec.2011.01.035
    Journal articles | 2011
    Goldstein D; Gainford MC; Brown C; Tebbutt N; Ackland SP; Van Hazel G; Jefford M; Abdi E; Selva-Nayagam S; Gebski V; Miller D; Shannon J, 2011, 'Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas', Cancer Chemotherapy and Pharmacology, vol. 67, pp. 519 - 525, http://dx.doi.org/10.1007/s00280-010-1351-8
    Journal articles | 2011
    Leighl N; Shepherd H; Butow PN; clarke SJ; Mcjannett M; Beale P; Wilken N; Moore M; Chen E; Goldstein D; Horvath LG; Knox J; Krzyzanowska M; Oza AM; Feld R; Hedley D; Xu W; Tattersall MH, 2011, 'Supporting treatment decision-making in advanced cancer: a randomized trial of a decision aid for patients considering chemotherapy in advanced colorectal cancer', Journal of Clinical Oncology, vol. 29, pp. 2077 - 2084, http://dx.doi.org/10.1200/JCO.2010.32.0754
    Journal articles | 2011
    Luckett T; Goldstein D; Butow PN; Gebski V; Aldridge L; McGrane J; Ng W; King MT, 2011, 'Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis', Lancet Oncology, vol. 12, pp. 1240 - 1248, http://dx.doi.org/10.1016/S1470
    Journal articles | 2011
    Luckett T; Goldstein D; Butow PN; Gebski V; Aldridge LJ; McGrane J; Ng W; King MT, 2011, 'Psychological morbidity and quality of life of ethnic minority patients with cancer: A systematic review and meta-analysis', The Lancet Oncology, vol. 12, pp. 1240 - 1248, http://dx.doi.org/10.1016/S1470-2045(11)70212-1
    Journal articles | 2011
    Park SB; Goldstein D; Lin CS-Y; Krishnan AV; Friedlander M; Kiernan MC, 2011, 'Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment?', Journal of clinical oncology - official journal of the American Society of Clinical Oncology, vol. 29, pp. e553 - e554e, http://dx.doi.org/10.1200/JCO.2011.34.8227
    Journal articles | 2011
    Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Dose effects of Oxaliplatin on persistent and transient na+ conductances and the development of neurotoxicity', PLoS One, vol. 6, pp. 1 - 7, http://dx.doi.org/10.1371/journal.pone.0018469
    Journal articles | 2011
    Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Long-term neuropathy after Oxaliplatin treatment: Challenging the dictum of reversibility', Oncologist, vol. 16, pp. 708 - 716, http://dx.doi.org/10.1634/theoncologist.2010-0248
    Journal articles | 2011
    Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy', Experimental Neurology, vol. 227, pp. 120 - 127, http://dx.doi.org/10.1016/j.expneurol.2010.10.002
    Journal articles | 2011
    Peng J; Shi D; Goodman KA; Goldstein D; Xiao C; Guan Z; Cai S, 2011, 'Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29', Radiation Oncology, vol. 6, http://dx.doi.org/10.1186/1748-717X-6-93
    Journal articles | 2011
    Tebbutt N; murphy F; Zannino D; Wilson D; Cummins MM; Abdi E; Strickland A; Lowenthal RM; Marx G; Karapetis C; Shannon JF; Goldstein D; Nayagam SS; Blum R; Chantrill L; Simes RJ; Price T, 2011, 'Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab', Annals of Oncology, vol. 22, pp. 1834 - 1838, http://dx.doi.org/10.1093/annonc/mdq702
    Journal articles | 2011
    Webber K; Cooper A; Kleiven H; Yip D; Goldstein D, 2011, 'Management of metastatic renal cell carcinoma in the era of targeted therapies', Internal Medicine Journal, vol. 41, pp. 594 - 605, http://dx.doi.org/10.1111/j.1445-5994.2011.02540.x
    Journal articles | 2011
    Zhi J; Major P; Chen E; Burns I; Robinson B; McKendrick J; Rittweger K; Abt M; Goldstein D, 2011, 'A multi-centre, randomised, open-lable study to assess the steady state paramacokinetics of Bevacizumab given with either Xeloda or FOLFOX-4 in patient with metastatic colorectal cancer', Cancer Chemotherapy and Pharmacology, vol. 68, pp. 1199 - 1206, http://dx.doi.org/10.1007/s00280-011-1606-z
    Journal articles | 2010
    Blinman P; Duric V; Nowak A; Beale P; Clarke SJ; Briscoe K; Boyce A; Goldstein D; Hudson M; Stockler M, 2010, 'Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile?', European Journal of Cancer, vol. 46, pp. 1800 - 1807, http://dx.doi.org/10.1016/j.ejca.2009.12.032
    Journal articles | 2010
    Butow PN; Sze M; Dugal-beri P; Mikhail M; Eisenbruch M; Jefford M; Schofield P; Girgis A; king M; Goldstein D, 2010, 'From inside the bubble: Migrants' perceptions of communication with the cancer tea', Supportive Care in Cancer, vol. 19, pp. 281 - 290, http://dx.doi.org/10.1007/s00520-010-0817-x
    Journal articles | 2010
    Goldstein D; Butow PN; Boyle F; Stockler M; Lovell M; Chye R; Forder P; Briganti E, 2010, 'A randomized controlled trial of a standardized educational intervention for patients with cancer pain', Journal of Pain and Symptom Management, vol. 49, pp. 49 - 59, http://dx.doi.org/10.1016/j.jpainsymman.2009.12.013
    Journal articles | 2010
    Goldstein D; Gill A; Chou A; Vilain R; Clarkson A; Lui M; Jin R; Tobias VH; Samral J; Smith C; Sioson L; Parker N; Smith R; Sywak M; Wyatt S; Robinson B; Eckstein R; Benn D; Clifton-bligh R, 2010, 'Immunohistochemistry for SDHB divides gastrointestinal stromal tumours (GISTs) into two distinct types', American Journal of Surgical Pathology, vol. 34, pp. 636 - 644, http://dx.doi.org/10.1097/PAS.0b013e3181d6150d
    Journal articles | 2010
    Goldstein D; Underhill CR; Olver IN; Kosczwara ; Kay F; Franca M, 2010, 'Reaching Further with Online Education? The Development of an Effective Online Program in Palliative Oncology', Journal of Cancer Education, vol. 25, pp. 317 - 323, http://dx.doi.org/10.1007/s13187-009-0037-6
    Journal articles | 2010
    Neoptolemos J; stocken D; bassi C; Goldstein D, 2010, 'Adjuvant chemotherapy with flurouracil plus folinic acid vs gemcitabine following pancreatic cancer resection:a randomsied trial JAMA 2010', JAMA - Journal of the American Medical Association, vol. 304, pp. 1073 - 1081, http://dx.doi.org/10.1001/jama.2010.1275
    Journal articles | 2010
    Rossleigh MA; Goldstein D, 2010, 'Treatment of Fluorouracil-Refractory Patients with Liver Metastases from Colorectal Cancer by Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy', Journal of Clinical Oncology, vol. 27, pp. 4089 - 4095, http://dx.doi.org/10.1200/JCO.2008.20.8116
    Journal articles | 2010
    Seth D; D'Souza el-Guindy NB; Apte MV; Mari M; Dooley S; Neumann M; Haber P; Kundu S; Darwanto A; De villiers WJ; Vonlaufen A; Xu Z; Phillips P; Yang S; Goldstein D; Pirola RM; Wilson JS; Moles A; Fernandez A; Colell A; Garcia-ruiz C; Fernandez-checa JC; Meyer C; Meindl-beinker N, 2010, 'Alcohol, signaling, and ECM turnover', Alcoholism : Clinical and Experimental Research, vol. 34, pp. 4 - 18, http://dx.doi.org/10.1111/j.1530-0277.2009.01060.x
    Journal articles | 2010
    Tebbutt NC; Wilson K; Gebski VJ; Cummins MM; Zannino D; Van Hazel GA; Robinson B; Broad A; Ganju V; Ackland SP; Forgeson G; Cunningham D; Saunders MP; Stockler MR; Chua Y; Zalcberg JR; Simes RJ; Price TJ; Coates A; O'Connell D; Brown C; Hague W; France A; Hicks S; James R; Masson R; O'Connell R; Pike R; Shoulder J; Stevens L; Tunney V; Vachan B; Wong N; Ackland S; Moylan E; Strickland A; Abdi E; Ransom D; Lowenthal R; Marx G; Nayagam SS; Shannon J; Goldstein D; Karapetis C; Blum R; Eek R; Ward R; Pavlakis N; Wilcken N; Burns I; Wyld D; Underhill C; Claringbold P; Liauw W; Clingan P; Jefford M; Horvath L; McKendrick J; Chong G; Boyce A; Cassidy J; Kirsten F; Clarke S; Guo Y; Innes-Rowe J; Smith A; Williams J; Tournier E; Maliepaard S; Vitullo E; Humm G; Nguyen V; Midolo P; Chorlton C; McDonald L; Oliver L; Sjursen AM; Inglis C; Marafioti T; McCourt J; Howard J; Richards A; Provis A; Rundle A; Whatman A; Emmett L; Raymond B; Byrne S; Withers E; Campbell J; Hodgkins C; Szwajcer M; Parker S; Welby S; Page F; Corker M; Wykes R; Goss C; Whitney S; Oates J, 2010, 'Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study', Journal of Clinical Oncology, vol. 28, pp. 3191 - 3198, http://dx.doi.org/10.1200/JCO.2009.27.7723
    Journal articles | 2010
    Xu ZH; Vonlaufen A; Phillips PA; Fiala-Beer E; Zhang X; Yang L; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2010, 'Role of pancreatic stellate cells in pancreatic cancer metastasis', American Journal of Pathology, vol. 177, pp. 2585 - 2596, http://dx.doi.org/10.2353/ajpath.2010.090899
    Journal articles | 2009
    Chua W; Goldstein D; Dhillon H; Mitchell P; Clarke SJ; Iacopetta BJ; Lee CK; Michael M, 2009, 'Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer', British Journal of Cancer, vol. 101, pp. 998 - 1004, http://dx.doi.org/10.1038/sj.bjc.6605239
    Journal articles | 2009
    Lee CK; Hadley A; Desilva K; Goldstein D, 2009, 'When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis', World Journal of Surgical Oncology, vol. 7, pp. 1 - 4, http://dx.doi.org/10.1186/1477-7819-7-8
    Journal articles | 2009
    Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC, 2009, 'Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity', Journal of clinical oncology - official journal of the American Society of Clinical Oncology, vol. 27, pp. 1243 - 1249, http://dx.doi.org/10.1200/JCO.2008.19.3425
    Journal articles | 2009
    Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced neurotoxicity: Changes in axonal excitability precede development of neuropathy', Brain, vol. 132, pp. 2712 - 2723, http://dx.doi.org/10.1093/brain/awp219
    Journal articles | 2009
    Underhill CR; Bartel R; Goldstein D; Snodgrass H; Begbie S; Yates P; White K; Jong K; Grogan P, 2009, 'Mapping oncology services in regional and rural Australia', Australian Journal of Rural Health, vol. 17, pp. 321 - 329, http://dx.doi.org/10.1111/j.1440-1584.2009.01106.x
    Journal articles | 2008
    Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander ML; Kiernan MC, 2008, 'Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, vol. 15, pp. 3081 - 3094, http://dx.doi.org/10.2174/092986708786848569
    Journal articles | 2007
    Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ, 2007, 'Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial', Lancet Oncology, vol. 8, pp. 603 - 612, http://dx.doi.org/10.1016/S1470-2045(07)70148-1
    Journal articles | 2006
    Barlow-Stewart K; Yeo SS; Meiser B; Goldstein D; Tucker K; Eisenbruch M, 2006, 'Towards cultural competence in cancer genetic counselling and genetics education: lessons learned from Chinese-Australians', Genetics in Medicine, vol. 8, pp. 24 - 32, http://dx.doi.org/10.1097/01.gim.0000195884.86201.a0
    Journal articles | 2006
    Goldstein D; Bennett BK; Friedlander ML; Davenport TA; Hickie IB; Lloyd AR, 2006, 'Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study', BMC Cancer, vol. 6, pp. 240 - 240, http://dx.doi.org/10.1186/1471-2407-6-240
    Journal articles | 2006
    Goldstein D; Spry N; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Australia EL, 2006, 'Combined modality therapy for pancreatic carcinoma: An Australian Pancreatic Cancer Group study of the addition of gemcitabine (G) to concurrent infusional 5-fluorouracil (CI 5FU) and 3D conformal radiotherapy (RT)-Final outcomes.', J Clin Oncol, vol. 24, pp. 4104, http://www.ncbi.nlm.nih.gov/pubmed/27953934
    Journal articles | 2006
    Grimison PS; T Chin M; Harrison ML; Goldstein D, 2006, 'Primary pancreatic lymphoma - pancreatic tumours that are potentially curable without resection, a retrospective review of four cases', BMC Cancer, vol. 6, http://dx.doi.org/10.1186/1471-2407-6-117
    Journal articles | 2006
    Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2006, 'Oxaliplatin and axonal Na+ channel function in vivo', Clinical Cancer Research, vol. 12, pp. 4481 - 4484, http://dx.doi.org/10.1158/1078-0432.CCR-06-0694
    Journal articles | 2006
    Mitchell P; Goldstein D; Beale P; Friedlander ML; Zalcberg J; White S; Thomson JA; Clarke S; Michael M, 2006, 'Addition of Gabapentin to a Modified FOLFOX Regimen Does Not Reduce Oxaliplatin-Induced Neurotoxicity', Clinical Colorectal Cancer, vol. 6, pp. 146 - 151, http://dx.doi.org/10.3816/CCC.2006.n.032
    Journal articles | 2006
    Shepherd LM; Goldstein D; Whitford H; Thewes B; Brummell V; Hicks M, 2006, 'The Utility of Videoconferencing to Provide Innovative Delivery of Psychological Treatment for Rural Cancer Patients: Results of a Pilot Study', Journal of Pain and Symptom Management, vol. 32, pp. 453 - 461, http://dx.doi.org/10.1016/j.jpainsymman.2006.05.018
    Journal articles | 2006
    Yip D; Karapetis C; Strickland C; Steer C; Goldstein D, 2006, 'Chemotherapy and radiotherapy for pancreatic cancer', Cochrane Database of Systematic Reviews, vol. 4, http://dx.doi.org/10.1002/14651858.CD011044.pub2
    Journal articles | 2005
    Burmeister B; Smithers M; Gebski V; Denham J; Devitt P; Ackland S; Findlay M; Dhillon H; Stockler M; Coates A; Matthews J; Simes J; Beller E; Fitzgerald L; Gray E; Dodds H; Marks P; Hayden P; Erratt A; Monro C; Pike R; Walpole E; Gotley D; Thomson D; Harvey J; Martin I; Burmeister E; Jamieson G; Borg M; Yeoh E; Olver I; Caruso D; Game P; Joseph D; Spry N; Minchin D; Cameron F; Faulkner K; Einhorn S; Dewar J; Gillies J; Johnson C; Kilmurray J; Neely M; Carmody M; Mackintosh J; Millar J; O'Brien P; Schwartz M; Smith R; Woods S; Nathanson L; O'Loughlin B; Grimes D; Cheuk R; Dickie G; Keller J; Archer S; Bayliss E; Gray B; Trotter J; Ransom D; Shepherd J; Stone C; Thompson I; Guiney M; Henderson M; Thomas R; Kian M; Ngan S; Rischin D; Walcher V; Zalcberg J; North J; Costello S; Perez D; Whitely D; Wyllie A; Avramovic J; Donnolly P; Fon P; Collins M; McIntosh R; Melville P; Bell R; Kirrof G; Harris I; McLennan R; Monro W; Aroney R; Falconer K; Cullingford G; Davidson A; Randell C; Berry M; Delaney G; Moylan E; Burns D; Goldstein D; Zissiadis M, 2005, 'Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial', Lancet Oncology, vol. 6, pp. 659 - 668, http://dx.doi.org/10.1016/S1470-2045(05)70288-6
    Journal articles | 2005
    Goldstein D; Mitchell P; Friedlander ML; Michael M; Beale P; Zalcberg JR; White S; Clarke SJ, 2005, 'Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients', British Journal of Cancer, vol. 92, pp. 832 - 837, http://dx.doi.org/10.1038/sj.bjc.6602426
    Journal articles | 2005
    Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2005, 'Oxaliplatin-induced neurotoxicity and the development of neuropathy', Muscle and Nerve, vol. 32, pp. 51 - 60, http://dx.doi.org/10.1002/mus.20340
    Journal articles | 2005
    Meiser B; Yeo SS; Barlow-Stewart K; Goldstein D; Tucker K; Eisenbruch M, 2005, 'Understanding community beliefs of Chinese-Australians about cancer: Initial insights using an ethnographic approach', Psycho - Oncology, vol. 14, pp. 174 - 186, http://dx.doi.org/10.1002/pon.831
    Journal articles | 2005
    Thewes B; Meiser B; Taylor AJ; Phillips KA; Pendlebury S; Capp A; Dalley D; Goldstein D; Baber R; Friedlander ML, 2005, 'Fertility - and Menoapuse-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer', Journal of Clinical Oncology, vol. 23, pp. 5155 - 5165, http://dx.doi.org/10.1200/JCO.2005.07.773
    Journal articles | 2004
    Goldstein D; Apte MV; Carroll SL; Keogh G, 2004, 'Modern management of pancreatic cancer', Internal Medicine Journal, vol. 34, pp. 475 - 481, http://dx.doi.org/10.1111/j.1444-0903.2004.00658.x
    Journal articles | 2004
    Goldstein D; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Spry N, 2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy', Journal of Clinical Oncology, vol. 22, pp. 4100 - 4100, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.4100
    Journal articles | 2004
    Goldstein D; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Spry N; Eli Lilly Australia , 2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy.', J Clin Oncol, vol. 22, pp. 4100, http://www.ncbi.nlm.nih.gov/pubmed/28014508
    Journal articles | 2004
    Hagerty RG; Butow PN; Ellis PA; Lobb EA; Pendlebury S; Leighl N; Goldstein D; Lo SK; Tattersall MH, 2004, 'Cancer Patient Preferences for Communication of Prognosis in the Metastatic Setting', Journal of Clinical Oncology, vol. 22, pp. 1721 - 1730, http://dx.doi.org/10.1200/JCO.2004.04.095
    Journal articles | 2004
    Robotin M; Law MG; Milliken ST; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE, 2004, 'Clinical features and predictors of survival of AIDS-related non-Hodgkin`s lymphoma in a population-based case series in Sydney, Australia', HIV Medicine, vol. 5, pp. 377 - 384, http://dx.doi.org/10.1111/j.1468-1293.2004.00238.x
    Journal articles | 2004
    Yang JL; Qu XJ; Russell PJ; Goldstein D, 2004, 'Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha', Gut, vol. 53, pp. 123 - 129, http://dx.doi.org/10.1136/gut.53.1.123
    Journal articles | 2003
    Eisenbruch IM; Yeo SS; Meiser B; Goldstein D; Tucker K; Barlow-Stewart K, 2003, 'Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians', Social Science and Medicine, vol. 59, pp. 235 - 248, http://dx.doi.org/10.1016/j.socscimed.2003.10.016
    Journal articles | 2001
    Boyer MJ; Mitchell P; Goldstein D; Millward MJ; Olver IN; Clarke SJ; Richardson GD; Davis I, 2001, 'Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer', Lung Cancer, vol. 32, pp. 89 - 94, http://dx.doi.org/10.1016/S0169-5002(00)00207-5
    Journal articles | 2001
    Eisenbruch IM; Barlow-Stewart K; Tucker K; Steel ZP; Goldstein D; Meiser B, 2001, 'Cultural aspects of cancer genetics: setting a research agenda', Journal of Medical Genetics, vol. 38, pp. 425 - 429
    Journal articles | 2001
    Ngan S; Burmeister B; Fisher R; Rischin D; Schache D; Kneebone A; Mackay J; Joseph D; Bell A; Goldstein D, 2001, 'Early Toxicity from Preoperative Radiotherapy with Continuous Infusion 5-Fluorouracil for Resectable Adenocarcinoma of the Rectum: A Phase II Trial for the Trans-Tasman Radiation', International Journal of Radiation Oncology and Biology Physics, vol. 50, pp. 883 - 887, http://dx.doi.org/10.1016/S0360-3016(01)01536-X
    Journal articles | 1996
    Goebel F; Goldstein D; Goos M; Jablonowski H; Stewart JS, 1996, 'Efficacy and safety of stealth liposomal doxorubicin in AIDS-related Kaposi`s sarcoma', British Journal of Cancer, vol. 73, pp. 989 - 994, http://dx.doi.org/10.1038/bjc.1996.193
    Journal articles | 1994
    Kaldor J; Elford J; Grulich A; Goldstein D, 1994, 'HIV AIDS and cancer', Cancer Forum, vol. 18, pp. 3 - 11
    Journal articles | 1991
    Goldstein D; O'Leary M; Mitchen J; Borden EC; Wilding G, 1991, 'Effects of interferon βser and transforming growth factor β on prostatic cell lines', Journal of Urology, vol. 146, pp. 1173 - 1177, http://dx.doi.org/10.1016/S0022-5347(17)38034-5
    Journal articles | 1989
    GOLDSTEIN D; SOSMAN JA; HANK JA; WEILHILLMAN G; MOORE KH; BORCHERT A; BECHHOFER R; STORER B; KOHLER PC; LEVITT D; SONDEL PM, 1989, 'REPETITIVE WEEKLY CYCLES OF INTERLEUKIN-2 - EFFECT OF OUTPATIENT TREATMENT WITH A LOWER DOSE OF INTERLEUKIN-2 ON NON-MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED KILLER ACTIVITY', CANCER RESEARCH, vol. 49, pp. 6832 - 6839, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1989CA66300061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
  • Preprints | 2022
    Kokkinos J; Sharbeen G; Ignacio RMC; Pandzic E; Youkhana J; Boyer C; Haghighi KS; Gunawarman M; Goldstein D; Gebski V; Pajic M; Pitiyarachchi O; Davis ME; Schulstad G; Arkell OSM; Kopecky C; Gonzales-Aloy E; Erkan M; Morton JP; Kavallaris M; Gunning PW; Hardeman EC; Johns A; Gill AJ; Whan RM; Mawson A; McCarroll JA; Phillips PA, 2022, βIII-Tubulin is a Brake on Extrinsic Cell-Death in Pancreatic Cancer, http://dx.doi.org/10.1101/2022.09.29.510034
    Conference Papers | 2021
    Lemech C; Dredge K; Bampton D; Hammond E; Clouson A; Waterhouse N; Stanley A; Leveque-ElMouttie L; Chojnowski G; Haydon A; Pavlakis N; Burge M; Brown M; Goldstein D, 2021, 'A PHASE IB EXPANSION COHORT OF PIXATIMOD PLUS NIVOLUMAB IN PREVIOUSLY TREATED, MICROSATELLITE STABLE METASTATIC COLORECTAL CANCER (MSS MCRC)', in JOURNAL FOR IMMUNOTHERAPY OF CANCER, BMJ PUBLISHING GROUP, pp. A367 - A367, http://dx.doi.org/10.1136/jitc-2021-SITC2021.341
    Conference Papers | 2021
    Lemech C; Dredge K; Bampton D; Hammond E; Stanley A; Leveque-ElMouttie L; Chojnowski G; Haydon A; Pavlakis N; Burge M; Brown M; Goldstein D, 2021, 'A PHASE IB STUDY OF THE SAFETY AND TOLERABILITY OF PIXATIMOD PLUS NIVOLUMAB IN SUBJECTS WITH ADVANCED SOLID TUMORS WITH AN EXPANSION COHORT IN METASTATIC PANCREATIC ADENOCARCINOMA (MPDAC)', in JOURNAL FOR IMMUNOTHERAPY OF CANCER, BMJ PUBLISHING GROUP, pp. A366 - A366, http://dx.doi.org/10.1136/jitc-2021-SITC2021.340
    Conference Papers | 2021
    Pavlakis N; Shitara K; Sjoquist K; Martin AJ; Jaworski A; Yip S; Oh D-Y; Moehler M; Chen L-T; Bekaii-Saab T; Simes J; Goldstein D, 2021, 'INTEGRATE IIb: A randomised phase III open label study of regorafenib plus nivolumab vs standard chemotherapy in refractory advanced gastro-oesophageal cancer (AGOC)', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, pp. S1074 - S1074, presented at Congress of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 16 September 2021 - 21 September 2021, http://dx.doi.org/10.1016/j.annonc.2021.08.1547
    Conference Abstracts | 2020
    Best M; Butow P; Jacobs C; Juraskova I; Savard J; Meiser B; Goldstein D; Ballinger M; Bartley N; Napier C; Davies G; Thomas D; Tucker K; Schlub T; Newson AJ, 2020, 'Advanced cancer patient preferences for receiving molecular profiling results', in Psycho-Oncology, WILEY, Vol. 29, pp. 1533 - 1539, http://dx.doi.org/10.1002/pon.5446
    Preprints | 2020
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey S; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill A; Gonzales-Aloy E; Kokkinos J; Gebski V; Turner N; Apte M; Davis TP; Morton JP; Haghighi K; Phillips PA, 2020, Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition, http://dx.doi.org/10.1101/2020.07.12.199638
    Conference Papers | 2019
    Hayes SA; Martin A; Yip S; Howell VM; Sjoquist KM; Tsobanis E; Kang Y-K; Bang Y-J; Alcindor T; O'Callaghan CJ; Tebbutt NC; Simes J; Goldstein D; Pavlakis N, 2019, 'SWATH-MS profiling identifies prognostic factors for progression- free survival (PFS) In INTEGRATE - A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC) - A study by the Australasian Gastrointestinal Trials Group (AGITG)', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-4531
    Conference Posters | 2019
    Iioanni L; maharaj A; loughan J; zalcberg J; earnest A; Goldstein D; Kench J; Merrett N; christophi C; croagh D; pilgrim C; burmeister E; white K; neale R; green S; evans S, 2019, 'Prognostic models to predict survival in patients with pancreatic cancer: A systematic review', Bangkok, presented at ASM RACS, Bangkok, 06 May 2019 - 10 May 2019
    Conference Papers | 2017
    Clifford B; Barry B; Simar D; Goldstein D, 2017, 'Exercise Induced Analgesia in Survivors of Cancer', in MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, LIPPINCOTT WILLIAMS & WILKINS, CO, Denver, pp. 163 - 163, presented at Annual Meeting of the American-College-of-Sports-Medicine (ACSM), CO, Denver, 30 May 2017 - 03 June 2017, http://dx.doi.org/10.1249/01.mss.0000517274.66389.d8
    Conference Abstracts | 2017
    Meiser B; Kaur R; Zilliacus E; Wong T; Woodland L; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda S; Shaw T; Tebble H; Goldstein D, 2017, 'Evaluation of an Online Communication Skills Training Programme for Oncology Health Care Professionals Working with Culturally and Linguistically Diverse Patients', in Immunotherapy: Molecules and Mountains, Sydney, presented at COSA's 44th Annual Scientif Meeting, Sydney, http://dx.doi.org/10.1111/ajco.12798
    Conference Abstracts | 2017
    Meiser B; Kaur R; Zilliacus E; Wong T; Woodland L; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda SK; Shaw T; Tebble H; Goldstein D, 2017, 'Evaluation of an Online Communication Skills Training Programme for Oncology Health Care Professionals Working with Culturally and Linguistically Diverse Patients', in COSA's 44th Annual Scientific Meeting, Immunotherapy: Molecules and Mountains, WILEY, Vol. 13, pp. 66 - 66, presented at COSA's 44th Annual Scientific Meeting, 13 November 2017 - 15 November 2017, http://dx.doi.org/10.1111/ajco.12798
    Conference Papers | 2016
    Chan H; Roncolato F; Long A; Foroudi F; Goldstein D; Siva S; Davis I, 2016, 'CURRENT CLINICIAN PRACTICES IN UTILIZING RADIOTHERAPY AND MOLECULARLY TARGETED THERAPIES IN TREATING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: AN ANZUP SURVEY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000380004900064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Posters | 2015
    Lim HJ; Wang X; Goldstein ; Crowe , 2015, 'Targeting the PI3K/PTEN/AKT/mTOR pathway in sarcoma cell lines', Lorne, Victoria, Australia, Vol. 36, pp. 5765 - 5771, presented at 27th Lorne Cancer Conference 2015, Lorne, Victoria, Australia, 12 February 2015 - 14 February 2015, http://dx.doi.org/10.21873/anticanres.11160
    Conference Presentations | 2015
    Meiser B; Zilliacus E; Wong T; Girgis A; Butow P; Hale S; Kissane D; Perry A; Aranda S; Tomkins S; Hodges J; Norris C; Shaw T; Tebble H; Woodland L; Kaur R; Goldstein D, 2015, 'Communication skills training for oncology health care professionals working with culturally and linguistically diverse patients', Vol. 11, pp. 152 - 152, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800250&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Conference Abstracts | 2015
    Tempero MA; Cardin DB; Biankin A; Goldstein D; Moore M; O'Reilly EM; Philip PA; Riess H; Macarulla T; Yung L; Li M; Lu B, 2015, 'nab-paclitaxel (nab-P) plus gemcitabine (Gem) vs Gem alone as adjuvant treatment for resected pancreatic cancer (PC) in a phase III trial (APACT).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.tps4153
    Conference Posters | 2015
    Wang X; Crowe PJ; Goldstein D; Yang JL, 2015, 'Overcoming resistance of targeted EGFR/panHER monotherapy by inhibition of STAT3 escape pathway in sarcoma', Lorne, Victoria, Australia, Vol. 7, pp. 21496 - 21509, presented at 27th Lorne Cancer Conference 2015, Lorne, Victoria, Australia, 12 February 2015 - 14 February 2015, http://dx.doi.org/10.18632/oncotarget.7452
    Conference Abstracts | 2015
    Wang X; Goldstein D; Crowe P; Yang JL, 2015, 'Synergistic effects of concurrent inhibition of EGFR and STAT3 in soft tissue sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, AUSTRIA, Vienna, Vol. 51, pp. S704 - S705, presented at European Cancer Congress, AUSTRIA, Vienna, http://dx.doi.org/10.1016/S0959-8049(16)31921-9
    Conference Papers | 2014
    Chua YJ; Karapetis CS; Gebski V; O'Connell R; Begbie S; Nott LM; Cronk MF; Underhill C; Abdi EA; Van Hagen T; Wong N; Hall M; Ferraro DA; Sjoquist KM; Santos C; Mackey JR; Goldstein D, 2014, 'Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Gastrointestinal Cancers Symposium, CA, San Francisco, 16 January 2014 - 18 January 2014, http://dx.doi.org/10.1200/jco.2014.32.3_suppl.228
    Conference Papers | 2014
    Long A; Roncolato F; Foroudi F; Goldstein D; Davis I; Siva S, 2014, 'CURRENT CLINICIAN PRACTICES IN UTILISING RADIOTHERAPY AND TARGETED THERAPIES IN TREATING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA - A SURVEY OF AUSTRALIAN AND NEW ZEALAND CLINICIANS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 36 - 37, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339716200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Teo J; Boyer C; Sharbeen G; Sagnella S; Liu J; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J; Phillips PA, 2014, 'Design and Synthesis of Novel PEGylated Star Nanoparticles as Delivery Agents for Short-Interfering RNA (siRNA) to Pancreatic Cancer Cells', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1416 - 1416, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344362600356&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Teo J; Boyer C; Liu J; Sharbeen G; Erlich R; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J; Phillips PA, 2013, 'Inhibition of beta III-Tubulin Using a Novel Nanoparticle-siRNA Approach Sensitizes Pancreatic Cancer Cells to Chemotherapy', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1385 - 1385, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2010
    Goldstein D; Lee C; Hui Y; Shah B; Yip D; McArthur GA, 2010, 'Development of a nomogram to predict overall survival in patients with locally advanced or metastatic gastrointestinal stromal tumor receiving first-line treatment with imatinib', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.10054
    Conference Papers | 2007
    Goldstein D; Shannon J; Brown C; Tebbutt N; Ackland S; Van Hazel G; Abdi E; Jefford M; Gainford MC; Adams K, 2007, 'ABC; An AGITG trial of fixed dose rate (FDR) gemcitabine (gem) and cisplatin for patients (pts) with advanced biliary tract cancer (ABC)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000455043703565&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2006
    Joshi SB; Vonlaufen A; Xu Z; Daniel B; Qu CF; Kumar RK; Pirola RC; Wilson JS; Goldstein D; Apte MV, 2006, 'Pancreatic stellate cells stimulate pancreatic cancer growth and metastasis: Findings of a novel orthotopic model of pancreatic cancer', in Pancreas, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 472 - 473, - , http://dx.doi.org/10.1097/00006676-200611000-00123
    Conference Papers | 2005
    Joshi SB; Qu CF; Phillips PA; Pirola RC; Wilson JS; Goldstein D; Apte MV, 2005, 'Epithelial-stromal interactions in pancreatic cancer: do pancreatic cancer cells actively recruit host stromal cells for their own benefit?', in The Peter McCallum Institute (ed.), 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, pp. 21 - 21, presented at 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, 14 November 2005 - 16 November 2005

AGITG JOHN ZALCBERG AWARD FOR CLINICAL RESEARCH EXCELLENCE

CANCER INSTITUTE NSW MAKE A DIFFERENCE AWARD

PEOPLES HEALTH MEDAL VIETNAM 

Prof Goldstein has extensive clinical trial experience in both design and leadership. He also participated in a number of translational studies and is an active collaborator in three laboratory programs focused upon modeling of the use of targeted agents. His activity over many years in one of the least common cancers and least studied, until recently, in the GI area – pancreas cancer, as well as GIST and biliary cancers gives him great insight into the challenges of approaching a suite of rare cancers. He has also been involved in several large scale epidemiologic studies, the most recent looking at pancreatic cancer. He has contributed to pivotal data resulting in PBS changes in approval for adjuvant gemcitabine in pancreas cancer, imatinib in metastatic and adjuvant GIST and first line nab-paclitaxel in pancreatic cancer. 

My Research Supervision

cosupervising  2x PhD in pancreatic cancer biology, one in pancreatic cancer translational science